KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Raw Materials (2021 - 2023)

Historic Raw Materials for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Q2 2023 value amounting to $905000.0.

  • Ginkgo Bioworks Holdings' Raw Materials rose 486.67% to $905000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $905000.0, marking a year-over-year increase of 486.67%. This contributed to the annual value of $1.6 million for FY2022, which is 238437.5% up from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Raw Materials of $905000.0 as of Q2 2023, which was up 486.67% from $2.3 million recorded in Q1 2023.
  • Ginkgo Bioworks Holdings' Raw Materials' 5-year high stood at $2.3 million during Q1 2023, with a 5-year trough of $64000.0 in Q4 2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Raw Materials value was $884000.0 (recorded in 2022), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Raw Materials surged by 238437.5% in 2022, and later skyrocketed by 486.67% in 2023.
  • Ginkgo Bioworks Holdings' Raw Materials (Quarter) stood at $64000.0 in 2021, then soared by 2384.38% to $1.6 million in 2022, then crashed by 43.08% to $905000.0 in 2023.
  • Its Raw Materials stands at $905000.0 for Q2 2023, versus $2.3 million for Q1 2023 and $1.6 million for Q4 2022.